Zobrazeno 1 - 10
of 1 315
pro vyhledávání: '"Joris I"'
Autor:
Ni Made Hustrini, Endang Susalit, Felix Firyanto Widjaja, Anandhara Indriani Khumaedi, Olaf M. Dekkers, Merel van Diepen, Joris I. Rotmans
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 740-764 (2024)
Abstract Introduction Chronic kidney disease (CKD) etiology varies greatly between developed and developing countries. In addition, differences in underlying pathogenesis and therapeutic options affect the progression towards advanced-CKD. This meta-
Externí odkaz:
https://doaj.org/article/3bf0f742108346869ff011ef4941c224
Autor:
Zhuotao Xiao, Rudmer J. Postma, Anton Jan van Zonneveld, Bernard M. van den Berg, Wendy M.P.J. Sol, Nicholas A. White, Huybert J.F. van de Stadt, Asad Mirza, Jun Wen, Roel Bijkerk, Joris I. Rotmans
Publikováno v:
Materials Today Bio, Vol 27, Iss , Pp 101121- (2024)
Disturbed flow is one of the pathological initiators of endothelial dysfunction in intimal hyperplasia (IH) which is commonly seen in vascular bypass grafts, and arteriovenous fistulas. Various in vitro disease models have been designed to simulate t
Externí odkaz:
https://doaj.org/article/355f4da060c2491ebb47f7b3e71599bc
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
Autor:
Mireia Mato Prado, Jisce R. Puik, Leandro Castellano, Elena López-Jiménez, Daniel S. K. Liu, Laura L. Meijer, Tessa Y. S. Le Large, Eleanor Rees, Niccola Funel, Shivan Sivakumar, Stephen P. Pereira, Geert Kazemier, Babs M. Zonderhuis, Joris I. Erdmann, Rutger-Jan Swijnenburg, Andrea Frilling, Long R. Jiao, Justin Stebbing, Elisa Giovannetti, Jonathan Krell, Adam E. Frampton
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-7 (2023)
Abstract Differentiating between pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA) is crucial for the appropriate course of treatment, especially with advancements in the role of neoadjuvant chemotherapies for PDAC, compared to CCA
Externí odkaz:
https://doaj.org/article/4aa06997730e41ed9d09b56507c2f5e6
Autor:
Obbo W Bredewold, Ton J Rabelink, YK Onno Teng, Joris I Rotmans, Mieke van Schaik, Merel Priester, Wieneke M Michels
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/f2f7c07582454c40a4fdfd321aa95ade
Autor:
Lynn E. Nooijen, Maria Gustafsson-Liljefors, Joris I. Erdmann, Melroy A. D’Souza, Stefan Gilg, Christina Villard, Hannes Jansson
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-8 (2023)
Abstract Background For some patients undergoing resection under the suspicion of a perihilar cholangiocarcinoma (pCCA), postoperative diagnosis may differ from the preoperative diagnosis. While a postoperative finding of benign bile duct stricture i
Externí odkaz:
https://doaj.org/article/1fcfd9049ee5436499a3dc627964c9cb
Autor:
Daan Andel, Marnix G. E. H. Lam, Joep de Bruijne, Maarten L. J. Smits, Arthur J. A. T. Braat, Adriaan Moelker, Erik Vegt, Simeon J. S. Ruiter, Walter Noordzij, Gianluca Grazi, Giulio E. Vallati, Roel J. Bennink, Otto M. van Delden, Onno W. Kranenburg, Jan N. M. Ijzermans, Maarten W. Nijkamp, Joris I. Erdmann, Rosa Sciuto, Jeroen Hagendoorn, Inne H. M. Borel Rinkes
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remna
Externí odkaz:
https://doaj.org/article/0365f4d63da54b7a86f00d0c8e5c1b7c
Autor:
Frederik Haupenthal, Jette Rahn, Fabrizio Maggi, Fanny Gelas, Philippe Bourgeois, Christian Hugo, Bernd Jilma, Georg A. Böhmig, Harald Herkner, Michael Wolzt, Konstantin Doberer, Matthias Vossen, Daniele Focosi, Hannes Neuwirt, Miriam Banas, Bernhard Banas, Klemens Budde, Ondrej Viklicky, Paolo Malvezzi, Lionel Rostaing, Joris I. Rotmans, Stephan J. L. Bakker, Kathrin Eller, Daniel Cejka, Alberto Molina Pérez, David Rodriguez-Arias, Franz König, Gregor Bond, the TTVguideTX consortium partners
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-22 (2023)
Abstract Background Immunosuppression after kidney transplantation is mainly guided via plasma tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The plasma load of the non-pathogenic and highly prevalent to
Externí odkaz:
https://doaj.org/article/20431b7dfd564fe1995fc701d439b0ab
Autor:
Lenka N. C. Boyd, Lynn E. Nooijen, Mahsoem Ali, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large, Joris I. Erdmann, Gerrit K. J. Hooijer, Michal Heger, Hanneke W. M. Van Laarhoven, Eva Roos, Geert Kazemier, Elisa Giovannetti, Joanne Verheij, Heinz-Josef Klümpen
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Effective (neo) adjuvant chemotherapy for cholangiocarcinoma is lacking due to chemoresistance and the absence of predictive biomarkers. Human equilibrative nucleoside transporter 1 (hENT1) has been described as a potential prognostic a
Externí odkaz:
https://doaj.org/article/a8bd6725a9f1454dbc8b13795c5e0fbd
Autor:
Mike van Dooren, Elise A. J. de Savornin Lohman, Eva Brekelmans, Pauline A. J. Vissers, Joris I. Erdmann, Andries E. Braat, Jeroen Hagendoorn, Freek Daams, Ronald M. van Dam, Marieke T. de Boer, Peter B. van den Boezem, Bas Groot Koerkamp, Philip R. de Reuver
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-8 (2023)
Abstract Background Disseminated disease (DD) is often found at (re-)exploration in gallbladder cancer (GBC) patients. We aimed to assess the yield of staging laparoscopy (SL) and identify predictors for DD. Methods This retrospective study included
Externí odkaz:
https://doaj.org/article/7d418edb8fda4740aead3f5d213e10f9
Autor:
Alicia Furumaya, Lynn E. Nooijen, Martijn P. D. Haring, Hedy A. van Oers, Marlou van Beneden, Belle V. van Rosmalen, R. Bart Takkenberg, Geert Kazemier, Marc G. Besselink, Vincent E. de Meijer, Joris I. Erdmann, the Dutch Benign Liver Tumor Group
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Background Patient reported outcome measures (PROMs) may be useful for patients with benign liver tumours and cysts (BLTC) to evaluate the impact of treatment and/or guide shared decision making. Yet, a set of PROMs relevant to patients with
Externí odkaz:
https://doaj.org/article/c9fe75a55b3940d7af45cf804804d78d